C000017812 Performance — MetLife Mid Cap Stock Index Portfolio, Class B

Data updated: 2026-08-27

C000017812 returned +17.02% year to date and +25.17% over one year to Jun 2026. Annualised returns are +14.78% over 3 years and +8.48% over 5 years. The fund beat its US Mid-Cap Blend category average: $100 invested three years ago grew to $151, against $150 for the category, and to $125 over one year, against $122. Volatility over the past three years was 15.85% a year. In the 12 months to Jun 2026 the fund lost a net $79.2M, and assets reached $1.24B.

C000017812 Growth of $100

What $100 invested in MetLife Mid Cap Stock Index Portfolio grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Mid-Cap Blend category average over the same months.

PeriodC000017812Category average
1 year (Jul 2025 – Jun 2026)$125$122
3 years (Jul 2023 – Jun 2026)$151$150
5 years (Jul 2021 – Jun 2026)$150$147
Since data start (Jul 2019 – Jun 2026)$213$208

C000017812 Trailing Returns

Total returns to Jun 2026, from SEC N-PORT.

PeriodTotal return
YTD+17.02%
1 year+25.17%
3 years (annualised)+14.78%
5 years (annualised)+8.48%

C000017812 Annual Returns

Calendar-year total returns of MetLife Mid Cap Stock Index Portfolio, compounded from monthly SEC N-PORT returns. Partial years show the months covered.

YearTotal return
2026 (Jan–Jun)+17.02%
2025+6.86%
2024+13.34%
2023+15.77%
2022−13.45%
2021+24.06%
2020+13.15%
2019 (Jul–Dec)+6.65%

C000017812 Monthly Returns

Monthly total returns as reported on SEC Form N-PORT.

YearJanFebMarAprMayJunJulAugSepOctNovDec
2026+4.0%+4.1%−5.4%+7.8%+2.5%+3.5%——————
2025+3.8%−4.4%−5.5%−2.3%+5.4%+3.5%+1.6%+3.3%+0.4%−0.5%+2.0%0.0%
2024−1.8%+5.9%+5.5%−6.1%+4.4%−1.7%+5.8%−0.1%+1.1%−0.8%+8.7%−7.1%
2023+9.1%−1.8%−3.2%−0.8%−3.2%+9.1%+4.1%−2.9%−5.3%−5.4%+8.5%+8.7%
2022−7.2%+1.1%+1.3%−7.1%+0.7%−9.7%+10.8%−3.1%−9.2%+10.4%+6.1%−5.5%
2021+1.5%+6.8%+4.6%+4.5%+0.2%−1.1%+0.3%+1.9%−4.0%+5.9%−3.0%+5.0%
2020−2.6%−9.5%−20.2%+14.1%+7.2%+1.2%+4.6%+3.5%−3.3%+2.1%+14.2%+6.5%
2019——————+1.1%−4.2%+3.0%+1.1%+2.9%+2.8%

C000017812 Risk

Risk measures from monthly returns over Jul 2023 – Jun 2026.

  • 3-year volatility (annualised): 15.85%
  • 3-year Sharpe ratio: 0.65 (vs 4.5% risk-free rate)
  • Best month: +8.74% (Nov 2024)
  • Worst month: −7.14% (Dec 2024)

C000017812 Fund Flows

Monthly money in and out of MetLife Mid Cap Stock Index Portfolio, from SEC Form N-PORT.

  • 12-month net flow: −$79.2M
  • 12-month gross sales (incl. reinvestments): $172.6M
  • Sales ÷ redemptions: 0.69×
MonthSalesRedemptionsNet flow
Jun 2026$113.8M$29.6M$84.1M
May 2026$1.8M$22.9M−$21.1M
Apr 2026$23.1M$21.1M$2.0M
Mar 2026$2.7M$20.0M−$17.3M
Feb 2026$8.7M$25.9M−$17.2M
Jan 2026$2.0M$25.1M−$23.0M
Dec 2025$7.2M$20.6M−$13.4M
Nov 2025$2.0M$14.5M−$12.5M
Oct 2025$4.0M$11.9M−$7.8M
Sep 2025$2.3M$13.5M−$11.2M
Aug 2025$1.6M$19.6M−$18.0M
Jul 2025$3.3M$27.1M−$23.8M

C000017812 Assets Under Management

Net assets of MetLife Mid Cap Stock Index Portfolio by report date, from SEC N-PORT filings.

Report dateNet assets
2026-06-30$1.24B
2026-03-31$1.13B
2025-12-31$1.15B
2025-09-30$1.17B
2025-06-30$1.16B
2025-03-31$1.15B
2024-12-31$1.25B
2024-09-30$1.07B
2024-06-30$1.02B
2024-03-31$1.10B
2023-12-31$1.04B
2023-09-30$951.28M

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.